6
Total investments
0
Early stage
0
Mid stage
0
Late stage
15y
Years active
Portfolio
0 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
No investments found
Experience · 8 entries
All (8)
Investments (6)
Board (6)
2022
Board Member
Jan 2022
Vi är Sveriges ledande byrå för samhällsaktörer. Oavsett om du är en offentlig eller privat aktör, redan etablerad eller har målet att skapa dig en plats på samhällsarenan. Vi är en byrå för samhällsaktörer som vill nå resultat. För dig som vill utveckla samhället och demokratin. För dig som vill hitta nya lösningar. För samhällsaktörer som vill delta i det offentliga samtalet och bidra till förändring. I hela Sverige.
2019
Board Member
Jun 2019
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 41 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Twitter : @EFPIA
Website : www.efpia.eu
2015
S
Swedish Government's Life Science Advisory Board
Member
Jun 2015
2014
Board member
Apr 2014
Karolinska Institutet is one of the world´s leading medical universities. Our mission is to contribute to the improvement of human health through research and education.
Karolinska Institutet accounts for over 40 per cent of the medical academic research conducted in Sweden and offers the country´s broadest range of education in medicine and health sciences.
Since 1901 the Nobel Assembly at Karolinska Institutet has selected the Nobel laureates in Physiology or Medicine.
Karolinska Institutet was founded by King Karl XIII in 1810 as an "academy for the training of skilled army surgeons". Today, Karolinska Institutet is a modern medical university and one of the foremost in the world.
With our close relationship to the clinical milieu, a well established infrastructure and a stable financial situation, Karolinska Institutet has excellent prerequisites for sustaining high quality research and education.
2012
S
Swedish Anti Corruption Institute (Institutet mot Mutor)
Board Member
Jun 2012
Show all 8 entries ↓
Investment activity
2011–2022 · 6 investments
Recent (last 2 years)Earlier
